A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum

Caterina Longo, Guido Gambara, Virginia Espina, Alessandra Luchini, Barney Bishop, Alexis S. Patanarut, Emanuel F. Petricoin, Francesca Beretti, Barbara Ferrari, Enrico Garaci, Anto De Pol, Giovanni Pellacani, Lance A. Liotta

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: Melanoma represents only 4% of all skin cancers, but nearly 80% of skin cancer deaths. This manuscript applies several new measurement technologies with the purpose of elucidating molecular signatures of melanoma aggressiveness.Purpose: We sought to determine whether low-abundant serum proteins related to apoptotic pathways could be measured and correlated with defined melanoma subtypes. Hydrogel core shell nanoparticles, a new technology capable of selectively entrapping low molecular weight proteins and protecting them from enzymatic degradation, were used to capture candidate serum biomarkers. Biomarker levels were correlated with confocal microscopy, thereby representing a combination of new technologies for in vivo histologic documentation.Results: Among a panel of analyzed serum proteins, Bak was differentially expressed between nevi and melanomas. Melanomas with higher Bak serum levels exhibited more pronounced junctional activity on confocal imaging, whereas lesions with 'sparse' dermal nests had weak Bak expression.Conclusions: Our study links serum proteome analysis with confocal microscopic clinical in vivo histologic classification of melanomas. Bak has not been previously measured in serum. Bak differential expression among melanoma subtypes confirms the importance of the apoptotic pathway as a contributor to melanoma aggressiveness.

Original languageEnglish
Pages (from-to)29-34
Number of pages6
JournalExperimental Dermatology
Volume20
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Nanotechnology
Biomarkers
Melanoma
Blood Proteins
Skin
Serum
Confocal microscopy
Hydrogel
Proteome
Skin Neoplasms
Technology
Molecular weight
Nanoparticles
Imaging techniques
Degradation
Nevi and Melanomas
Confocal Microscopy
Documentation
Proteins
Molecular Weight

Keywords

  • Biomarker
  • in vivo confocal microscopy
  • Melanoma
  • Nanotechnology
  • Proteomics

ASJC Scopus subject areas

  • Dermatology
  • Molecular Biology
  • Biochemistry

Cite this

A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum. / Longo, Caterina; Gambara, Guido; Espina, Virginia; Luchini, Alessandra; Bishop, Barney; Patanarut, Alexis S.; Petricoin, Emanuel F.; Beretti, Francesca; Ferrari, Barbara; Garaci, Enrico; De Pol, Anto; Pellacani, Giovanni; Liotta, Lance A.

In: Experimental Dermatology, Vol. 20, No. 1, 01.2011, p. 29-34.

Research output: Contribution to journalArticle

Longo, C, Gambara, G, Espina, V, Luchini, A, Bishop, B, Patanarut, AS, Petricoin, EF, Beretti, F, Ferrari, B, Garaci, E, De Pol, A, Pellacani, G & Liotta, LA 2011, 'A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum', Experimental Dermatology, vol. 20, no. 1, pp. 29-34. https://doi.org/10.1111/j.1600-0625.2010.01187.x
Longo, Caterina ; Gambara, Guido ; Espina, Virginia ; Luchini, Alessandra ; Bishop, Barney ; Patanarut, Alexis S. ; Petricoin, Emanuel F. ; Beretti, Francesca ; Ferrari, Barbara ; Garaci, Enrico ; De Pol, Anto ; Pellacani, Giovanni ; Liotta, Lance A. / A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum. In: Experimental Dermatology. 2011 ; Vol. 20, No. 1. pp. 29-34.
@article{4e50e4d012d547d89b49613c623c05af,
title = "A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum",
abstract = "Background: Melanoma represents only 4{\%} of all skin cancers, but nearly 80{\%} of skin cancer deaths. This manuscript applies several new measurement technologies with the purpose of elucidating molecular signatures of melanoma aggressiveness.Purpose: We sought to determine whether low-abundant serum proteins related to apoptotic pathways could be measured and correlated with defined melanoma subtypes. Hydrogel core shell nanoparticles, a new technology capable of selectively entrapping low molecular weight proteins and protecting them from enzymatic degradation, were used to capture candidate serum biomarkers. Biomarker levels were correlated with confocal microscopy, thereby representing a combination of new technologies for in vivo histologic documentation.Results: Among a panel of analyzed serum proteins, Bak was differentially expressed between nevi and melanomas. Melanomas with higher Bak serum levels exhibited more pronounced junctional activity on confocal imaging, whereas lesions with 'sparse' dermal nests had weak Bak expression.Conclusions: Our study links serum proteome analysis with confocal microscopic clinical in vivo histologic classification of melanomas. Bak has not been previously measured in serum. Bak differential expression among melanoma subtypes confirms the importance of the apoptotic pathway as a contributor to melanoma aggressiveness.",
keywords = "Biomarker, in vivo confocal microscopy, Melanoma, Nanotechnology, Proteomics",
author = "Caterina Longo and Guido Gambara and Virginia Espina and Alessandra Luchini and Barney Bishop and Patanarut, {Alexis S.} and Petricoin, {Emanuel F.} and Francesca Beretti and Barbara Ferrari and Enrico Garaci and {De Pol}, Anto and Giovanni Pellacani and Liotta, {Lance A.}",
year = "2011",
month = "1",
doi = "10.1111/j.1600-0625.2010.01187.x",
language = "English",
volume = "20",
pages = "29--34",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum

AU - Longo, Caterina

AU - Gambara, Guido

AU - Espina, Virginia

AU - Luchini, Alessandra

AU - Bishop, Barney

AU - Patanarut, Alexis S.

AU - Petricoin, Emanuel F.

AU - Beretti, Francesca

AU - Ferrari, Barbara

AU - Garaci, Enrico

AU - De Pol, Anto

AU - Pellacani, Giovanni

AU - Liotta, Lance A.

PY - 2011/1

Y1 - 2011/1

N2 - Background: Melanoma represents only 4% of all skin cancers, but nearly 80% of skin cancer deaths. This manuscript applies several new measurement technologies with the purpose of elucidating molecular signatures of melanoma aggressiveness.Purpose: We sought to determine whether low-abundant serum proteins related to apoptotic pathways could be measured and correlated with defined melanoma subtypes. Hydrogel core shell nanoparticles, a new technology capable of selectively entrapping low molecular weight proteins and protecting them from enzymatic degradation, were used to capture candidate serum biomarkers. Biomarker levels were correlated with confocal microscopy, thereby representing a combination of new technologies for in vivo histologic documentation.Results: Among a panel of analyzed serum proteins, Bak was differentially expressed between nevi and melanomas. Melanomas with higher Bak serum levels exhibited more pronounced junctional activity on confocal imaging, whereas lesions with 'sparse' dermal nests had weak Bak expression.Conclusions: Our study links serum proteome analysis with confocal microscopic clinical in vivo histologic classification of melanomas. Bak has not been previously measured in serum. Bak differential expression among melanoma subtypes confirms the importance of the apoptotic pathway as a contributor to melanoma aggressiveness.

AB - Background: Melanoma represents only 4% of all skin cancers, but nearly 80% of skin cancer deaths. This manuscript applies several new measurement technologies with the purpose of elucidating molecular signatures of melanoma aggressiveness.Purpose: We sought to determine whether low-abundant serum proteins related to apoptotic pathways could be measured and correlated with defined melanoma subtypes. Hydrogel core shell nanoparticles, a new technology capable of selectively entrapping low molecular weight proteins and protecting them from enzymatic degradation, were used to capture candidate serum biomarkers. Biomarker levels were correlated with confocal microscopy, thereby representing a combination of new technologies for in vivo histologic documentation.Results: Among a panel of analyzed serum proteins, Bak was differentially expressed between nevi and melanomas. Melanomas with higher Bak serum levels exhibited more pronounced junctional activity on confocal imaging, whereas lesions with 'sparse' dermal nests had weak Bak expression.Conclusions: Our study links serum proteome analysis with confocal microscopic clinical in vivo histologic classification of melanomas. Bak has not been previously measured in serum. Bak differential expression among melanoma subtypes confirms the importance of the apoptotic pathway as a contributor to melanoma aggressiveness.

KW - Biomarker

KW - in vivo confocal microscopy

KW - Melanoma

KW - Nanotechnology

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=78650186000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650186000&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0625.2010.01187.x

DO - 10.1111/j.1600-0625.2010.01187.x

M3 - Article

VL - 20

SP - 29

EP - 34

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 1

ER -